REQUEST A DEMO
Total
USD $0.00
Search more companies

Anhui Anke Biotechnology (Group) Co.,Ltd. (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing | Management of Companies and Enterprises
Full name: Anhui Anke Biotechnology (Group) Co.,Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Anhui Anke Biotechnology (Group) Co., Ltd., founded in2000, have developed quickly and made remarkable success inthe field of bio- technology.The dominant products, Recombinant Human Growth Hormone(Ansomone, HGH), Series of Recombinant Human Interferon a2b(Anterferon), MAR Kit for Anti-sperm Antibody and etc., areall developed independently. These products have more andmore significant therapeutically effect on clinical testingand application of many kinds of intractable disease such aschronic hepatitis B, tumor, leukemia, nutritional supportburned wound and immunopurification sterility and etc.The subsidiary companies like Anhui Anke YuliangqingPharmaceutical Co., Ltd., Anhui Anke Hengyi PharmaceuticalCo., Ltd. and Anhui Anke Xinxin Pharmaceutical Co., Ltd havebeen established from recombination of Anqing YuliangqingPharmaceutical Co., Ltd.,Tongling NO.1 PharmaceuticalCompany dominated by Anke biotechnology Co.,Ltd. since year2000.The products are extended from biomedical products intomodern Chinese herb medicines and synthetic medicines.The sales networks of our products have covered more than30 provinces in China. More than 40 Regional Offices ofAnkeBio have built up in the whole China and theinternational Co-operation has developed quickly.The mission of AnkeBio is discovering, developing,manufacturing and marketing health-care products with HigherQuality as well as Best Services to improving life qualityof human.

Headquarters
K-1, Customs Road, High-tech Zone, No. 669, Changjiang West Road, Hefei, Anhui Province
Hefei; Anhui; Postal Code: 230088

Contact Details: Purchase the Anhui Anke Biotechnology (Group) Co.,Ltd. report to view the information.

Website: http://www.ankebio.com

Basic Information
Total Employees:
Purchase the Anhui Anke Biotechnology (Group) Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Anhui Anke Biotechnology (Group) Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Anhui Anke Biotechnology (Group) Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Anhui Anke Biotechnology (Group) Co.,Ltd. report to view the information.
Incorporation Date:
September 28, 2000
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
26.5%
Purchase this report to view the information.
6.85%
Purchase this report to view the information.
1.84%
Purchase this report to view the information.
1.45%
Purchase this report to view the information.
1.23%
Subsidiaries
Anhui Anke Hengyi Pharmaceutical Co., Ltd.
100%
Anhui Anke Huazhen Biotechnology Co., Ltd.
100%
Anhui Anke Yu Liangqing Pharmaceutical Co., Ltd
100%
Company Performance
Financial values in the chart are available after Anhui Anke Biotechnology (Group) Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-4.95%
Total operating revenue
-4.33%
Operating profit (EBIT)
-8.99%
Net Profit (Loss) for the Period
-9.74%
Total assets
8.71%
Total equity
10.98%
Operating Profit Margin (ROS)
-1.62%
Net Profit Margin
-1.66%
Return on Equity (ROE)
-3.33%
Quick Ratio
0.06%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?